world
Anvisa aprova caneta para diabetes que combina insulina e semaglutida
Poder360
September 28, 2026
via Poder360You're reading one story from Newsaly
Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.
A World Of News, One Window.
Explore Today's News
Kyinsu é indicado para adultos com diabetes tipo 2 e reúne em uma única aplicação semanal insulina basal e agonista de GLP-1
Read the full story
Explore More On Newsaly
Voices (0)
Share a 15-second voice reaction. Voices automatically disappear after 10 days.
Sign in to record a voice on this article.
Be the first to share a voice on this article.